LOS ANGELES--(BUSINESS WIRE)--Capricor Therapeutics, Inc. (OTCBB: CAPR), a diversified heart failure biotechnology company, today announced that, effective today, the Company’s common stock commences trading on the OTC Markets under the new symbol “CAPR.” The previous trading symbol was “NLTXD.” The ticker symbol change follows the recently completed merger between Capricor, Inc. and Nile Therapeutics, Inc.
Help employers find you! Check out all the jobs and post your resume.
